Prevalence of BRCA1 expression in epithelial ovarian cancer: immunohistochemical study.
No Thumbnail Available
Date
2007-01-12
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The 99 formalin fxed paraffin-embedded ovarian tissue specimens of Epithelial Ovarian Cancer (EOC) patients treated at the Gynecologic Oncology Unit, King Chulalongkorn Memorial Hospital between January 1, 1996 and December 31, 1999, were immuno-stained with BRCA antibody using the immunohistochemical method. According to the criteria for BRCA1 immunohistochemical evaluation (neoplastic nuclear staining more than 10%), 12 (12.1%) of the 99 specimens showed positive BRCA1 expression. No associated statistical significance between clinicopathological variables and BRCA expression was detected. Survival analysis was performed in 87 patients who were followed-up for more than 6 months and recent status were available. During a median follow-up of 43 months, median survival time was 46 months (range 6-84 months). No association between BRCA1 expression and survival outcomes was found (Disease free survival and overall survival) in the presented patients.
Description
Chotmaihet Thangphaet.
Keywords
Citation
Sirisabya N, Manchana T, Termrungreunglert W, Triratanachat S, Charuruks N, Tresukosol D. Prevalence of BRCA1 expression in epithelial ovarian cancer: immunohistochemical study. Journal of the Medical Association of Thailand. 2007 Jan; 90(1): 9-14